Clinical trials recruiting in Joensuu, Finland

Phase breakdown

Conditions recruiting in Joensuu, Finland

Recruiting trials in Joensuu, Finland

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
  NCT06430801 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female)
• ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
  NCT01301885 · Phase: Not specified · Ages: 19 Years to 48 Years · Sex: Female
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Joensuu, Finland?

3 recruiting trials have at least one study site in Joensuu, Finland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.